The Third Nationwide Korean Heart Failure III Registry (KorHF III):The Study Design Paper
- Author:
Minjae YOON
1
;
Eung Ju KIM
;
Seong Woo HAN
;
Seong-Mi PARK
;
In-Cheol KIM
;
Myeong-Chan CHO
;
Hyo-Suk AHN
;
Mi-Seung SHIN
;
Seok Jae HWANG
;
Jin-Ok JEONG
;
Dong Heon YANG
;
Jae-Joong KIM
;
Jin Oh CHOI
;
Hyun-Jai CHO
;
Byung-Su YOO
;
Seok-Min KANG
;
Dong-Ju CHOI
Author Information
- Publication Type:Trial Design
- From: International Journal of Heart Failure 2024;6(2):70-75
- CountryRepublic of Korea
- Language:English
- Abstract: With advancements in both pharmacologic and non-pharmacologic treatments, significant changes have occurred in heart failure (HF) management. The previous Korean HF registries, namely the Korea Heart Failure Registry (KorHF-registry) and Korean Acute Heart Failure Registry (KorAHF-registry), no longer accurately reflect contemporary acute heart failure (AHF) patients. Our objective is to assess contemporary AHF patients through a nationwide registry encompassing various aspects, such as clinical characteristics, management approaches, hospital course, and long-term outcomes of individuals hospitalized for AHF in Korea. This prospective observational multicenter cohort study (KorHF III) is organized by the Korean Society of Heart Failure. We aim to prospectively enroll 7,000 or more patients hospitalized for AHF at 47 tertiary hospitals in Korea starting from March 2018. Eligible patients exhibit signs and symptoms of HF and demonstrate either lung congestion or objective evidence of structural or functional cardiac abnormalities in echocardiography, or isolated right-sided HF. Patients will be followed up for up to 5 years after enrollment in the registry to evaluate long-term clinical outcomes. KorHF III represents the nationwide AHF registry that will elucidate the clinical characteristics, management strategies, and outcomes of contemporary AHF patients in Korea.
